Sotera Health updates board after director resignation
Sotera Health Company reported a governance change involving its Board of Directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Sotera Health Company reported a governance change involving its Board of Directors. On August 11, 2026, James C. Neary notified the Board of his resignation as a Class I director, effective August 13, 2026. The company states that Mr. Neary’s resignation was not due to any disagreement with the company regarding its operations, policies or practices. In connection with this resignation, the Board set its size at eleven directors as of the effective date.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Figures
Effective resignation date: August 13, 2026
Board size after change: 11 directors
Resignation notice date: August 11, 2026
3 metrics
Effective resignation date
August 13, 2026
Effective date of James C. Neary’s resignation as Class I director
Board size after change
11 directors
Board size fixed as of the effective resignation date
Resignation notice date
August 11, 2026
Date Neary notified the Board of his resignation
Key Terms
Form 8-K, Class I director, Emerging growth company
3 terms
Form 8-K regulatory
"FORM 8-K Pursuant to Section 13 or 15(d) of the Securities Exchange Act"
A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.
Class I director regulatory
"his resignation as a Class I director, effective August 13, 2026"
A class I director is a member of a company’s board who belongs to one of several groups whose terms expire in a specified year under a staggered election system; each class is elected on a different cycle so only a portion of the board faces re-election each year. This matters to investors because it affects how quickly control of the board can change, the company’s continuity and oversight, and the ease of mounting or defending against takeover efforts—think of a team where only some players are replaced each season rather than the whole roster at once.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What board change did Sotera Health Company (SHC) disclose in this 8-K?
Sotera Health Company disclosed that James C. Neary notified the Board on August 11, 2026 of his resignation as a Class I director, effective August 13, 2026, and the Board size was set at eleven directors as of that date.
When is James C. Neary’s resignation from Sotera Health (SHC) effective?
James C. Neary’s resignation as a Class I director is effective on August 13, 2026. He notified Sotera Health’s Board on August 11, 2026, and the Board subsequently adjusted its size to eleven directors as of the effective date.
Did James C. Neary resign from Sotera Health (SHC) due to a disagreement?
No. Sotera Health states that James C. Neary’s resignation was not the result of any disagreement with the company on matters relating to its operations, policies or practices, indicating an absence of reported dispute behind his departure.
What is the new size of Sotera Health’s (SHC) Board after the resignation?
Following James C. Neary’s resignation effective August 13, 2026, Sotera Health’s Board set its size at eleven directors. This adjustment reflects the board composition going forward and was made in connection with his departure as a Class I director.
Which SEC form did Sotera Health (SHC) use to report the director resignation?
Sotera Health reported the resignation of director James C. Neary on Form 8-K under the item covering departures of directors and certain officers, elections of directors, appointments of officers, and compensatory arrangements of certain officers.
AI-generated analysis. How Rhea-AI works. Not financial advice.
